About the CARE Project

35,278 people contributed to the global health effort to learn more about COVID-19, its treatments and vaccines.
These are important public health questions we were able to address in our recent publications, thanks to your contributions
  • What symptoms were present in early COVID-19?

  • What was the effectiveness of vaccines in the real-world?

  • How frequent are acute reactions to COVID-19 vaccination and who is at risk?

  • How common were breakthrough infections after vaccinations?

  • Is there a link between people who have autoimmune disease and long COVID?

  • Can the same study design used to evaluate flu vaccine effectiveness also be used to examine the effectiveness of COVID-19 vaccines?

  • Are COVID-19 vaccinations safe for pregnant women?

IQVIA is proud to have joined the global fight against COVID-19. As a leader in health data and a trusted partner of healthcare institutions, our goal is to help patients, healthcare providers, governments, the life science industry and others understand what’s happening and how we can reduce the impact of this virus, together.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry dedicated to delivering actionable insights.
For more information about IQVIA, please visitIQVIA.com
To learn more about IQVIA’s commitment to fight against COVID-19, clickhere